Search
for
Sort by
Research 30 of 82
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- Revising the role of the androgen receptor in breast cancer
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Redefining hormone resistance in prostate cancer
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation
- Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 <i>in vitro</i> infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19
- Editorial: Androgen-dependent diseases and their treatment
- Management of Advanced Prostate Cancer Undergoing Major Shift
- New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics
- Hormone Blocking Anticancer Drugs
- Reporting on Adverse Clinical Events
- Alopecia With Endocrine Therapies in Patients With Cancer
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Androgenic Effects on Ventricular Repolarization
- Investigation of Suicidality and Psychological Adverse Events in Patients Treated With Finasteride
- Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress
- Androgen receptor: A promising therapeutic target in breast cancer
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- A Review on Steroidal 5α-Reductase Inhibitors for Treatment of Benign Prostatic Hyperplasia
- Targets to treat androgen excess in polycystic ovary syndrome
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- COVID‐19, androgens, and androgenic alopecia
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Androgen Receptor Ligands: Agonists and Antagonists